Israeli drug company Kamada reports that on recent clinical trials done with its Glassia drug, results have shown positive results for treating lung disease. Laboratory mice with bacterial lung infection have shown significant improvement once treated with the drug.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

$10M Investment For SaNOtize Covid Nasal Spray
August 08, 2022

Beware: Flirting Online Can Ruin Your Relationship
August 08, 2022

PepsiCo Orders 30,000 Shipping Pallets Made From Waste
August 07, 2022

Tech Being Tested For Israel's First Wave-Powered Energy Station
August 07, 2022
Facebook comments